At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4583 Monkeypox Concept
Closed 07-20 16:00:00 EDT
1,885.45
-18.29
-0.96%
High1,917.70Low1,883.59Vol17.03M
Open1,903.86D1 Closing1,903.74Amplitude1.79%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O870.88MT/O Rate--Tradable Shares0.00
P/B4.596027ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared to Competitors
Dow Jones  ·  05:25
Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared to Competitors
Quest Diagnostics Inc. Stock Underperforms Monday When Compared to Competitors
Dow Jones  ·  05:04
Quest Diagnostics Inc. Stock Underperforms Monday When Compared to Competitors
Tonix Pharmaceuticals Publishes Investor Deck Highlighting Tonmya Fibromyalgia Launch Strategy
Reuters  ·  07-20 19:17
Tonix Pharmaceuticals Publishes Investor Deck Highlighting Tonmya Fibromyalgia Launch Strategy
Is Viatris (VTRS) Reframing Its Musculoskeletal Strategy Through the AAOS Pain Management Partnership?
Simply Wall St.  ·  07-18 23:23
Is Viatris (VTRS) Reframing Its Musculoskeletal Strategy Through the AAOS Pain Management Partnership?
Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors
Dow Jones  ·  07-18
Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors
Gilead’s Zamzetoclax Trial Update: What a Terminated Phase 1 Means for GILD Investors
TIPRANKS  ·  07-18
Gilead’s Zamzetoclax Trial Update: What a Terminated Phase 1 Means for GILD Investors
NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-07-17
Reuters  ·  07-17
NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-07-17
Viatris (VTRS) Draws Fresh Attention Following Pain Management Partnership And Undervalued Narrative
Simply Wall St.  ·  07-17
Viatris (VTRS) Draws Fresh Attention Following Pain Management Partnership And Undervalued Narrative
The Bull Case For Quest Diagnostics (DGX) Could Change Following Oncology Test Integration Into OncoEMR - Learn Why
Simply Wall St.  ·  07-17
The Bull Case For Quest Diagnostics (DGX) Could Change Following Oncology Test Integration Into OncoEMR - Learn Why
Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors
Dow Jones  ·  07-17
Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors
Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day
Dow Jones  ·  07-17
Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day
Gilead Chief Comm & Corp Aff Officer Johanna Mercier Sells 3,000 Shares for $389,757.60
Reuters  ·  07-17
Gilead Chief Comm & Corp Aff Officer Johanna Mercier Sells 3,000 Shares for $389,757.60
Tonix Pharmaceuticals Investor Deck Spotlights Tonmya Fibromyalgia Launch and Late-stage Pipeline Plans
Reuters  ·  07-17
Tonix Pharmaceuticals Investor Deck Spotlights Tonmya Fibromyalgia Launch and Late-stage Pipeline Plans
Gilead Targets Long-Acting HIV Regimens With New Injectable Study
TIPRANKS  ·  07-17
Gilead Targets Long-Acting HIV Regimens With New Injectable Study
Virax Biolabs Signs Fosun Diagnostics Supply Deal for Immuneselect in Six Southeast Asian Markets
Reuters  ·  07-16
Virax Biolabs Signs Fosun Diagnostics Supply Deal for Immuneselect in Six Southeast Asian Markets
Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared to Competitors
Dow Jones  ·  07-16
Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared to Competitors
Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day
Dow Jones  ·  07-16
Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day
Gilead Bdrs in Brazil Undergo 6-for-1 Stock Split, Ratio Shifts to 1:12
Reuters  ·  07-16
Gilead Bdrs in Brazil Undergo 6-for-1 Stock Split, Ratio Shifts to 1:12
Tonix Publishes Journal of Virology Study Showing 2022 Mpox Clade Iib up to 100,000-fold Less Virulent than 2003 Clade Iia
Reuters  ·  07-15
Tonix Publishes Journal of Virology Study Showing 2022 Mpox Clade Iib up to 100,000-fold Less Virulent than 2003 Clade Iia
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models
GlobeNewswire  ·  07-15
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models

Introduction

Company Name.
BK4583
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--